These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 6731461

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis].
    Marichal JF, Faller B, Mengus C, Wagner JD, Frey G.
    Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Successful salvage of peritoneal catheter in unresolved methicillin-resistant staphylococcus aureus peritonitis by combination treatment with daptomycin and rifampin.
    Lin SY, Ho MW, Liu JH, Liu YL, Yeh HC, Hsieh TL, Wang IK, Lin HH, Huang CC.
    Blood Purif; 2011; 32(4):249-52. PubMed ID: 21846982
    [Abstract] [Full Text] [Related]

  • 5. Methicillin-resistant staphylococcal infections in an outpatient peritoneal dialysis program.
    Holley JL, Bernardini J, Johnston JR, Piraino B.
    Am J Kidney Dis; 1990 Aug; 16(2):142-6. PubMed ID: 2382651
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD.
    Vargemezis V, Thodis E, Pasadakis P, Martinis G, Kousta E.
    Adv Perit Dial; 1990 Aug; 6():123-5. PubMed ID: 1982788
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
    Klaus G, Schaefer F, Müller-Wiefel D, Mehls O.
    Adv Perit Dial; 1995 Aug; 11():296-301. PubMed ID: 8534728
    [Abstract] [Full Text] [Related]

  • 10. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 2000 Aug; 16():280-4. PubMed ID: 11045311
    [Abstract] [Full Text] [Related]

  • 11. Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Sesso R, Draibe S, Castelo A, Sato I, Leme I, Barbosa D, Ramos O.
    Clin Nephrol; 1989 May; 31(5):264-8. PubMed ID: 2736815
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Kobayashi K, Nakamoto H, Okada S, Hoshitani K, Uchida K, Arima H, Shoda J, Takane Y, Ikeda N, Sugahara S, Okada H, Suzuki H.
    Adv Perit Dial; 2006 May; 22():65-8. PubMed ID: 16983942
    [Abstract] [Full Text] [Related]

  • 13. Imipenem/cilastatin sodium in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitis.
    Lui SF, Cheng AB, Leung CB, Wong KC, Li PK, Lai KN.
    Am J Nephrol; 1994 May; 14(3):182-6. PubMed ID: 7977477
    [Abstract] [Full Text] [Related]

  • 14. Peritonitis due to Staphylococcus sciuri in a patient on continuous ambulatory peritoneal dialysis.
    Wallet F, Stuit L, Boulanger E, Roussel-Delvallez M, Dequiedt P, Courcol RJ.
    Scand J Infect Dis; 2000 May; 32(6):697-8. PubMed ID: 11200385
    [Abstract] [Full Text] [Related]

  • 15. Predictive factors of outcome following staphylococcal peritonitis in continuous ambulatory peritoneal dialysis.
    de Lourdes Ribeiro de Souza da Cunha M, Montelli AC, Fioravante AM, Neves Batalha JE, Teixeira Caramori JC, Barretti P.
    Clin Nephrol; 2005 Nov; 64(5):378-82. PubMed ID: 16312266
    [Abstract] [Full Text] [Related]

  • 16. Effect of glucose in dialysis fluid on antibacterial defence in the peritoneal cavity.
    Calame W, Hendrickx RJ, Namavar F, Oe LP, Beelen RH.
    J Infect; 1995 May; 30(3):227-33. PubMed ID: 7673747
    [Abstract] [Full Text] [Related]

  • 17. Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
    Pignatari A, Pfaller M, Hollis R, Sesso R, Leme I, Herwaldt L.
    J Clin Microbiol; 1990 Sep; 28(9):1898-902. PubMed ID: 2172293
    [Abstract] [Full Text] [Related]

  • 18. Coagulase-negative staphylococcal peritonitis: outcomes of cephalosporin-resistant strains.
    Heywood A, Bargman JM.
    Adv Perit Dial; 2010 Sep; 26():34-6. PubMed ID: 21348376
    [Abstract] [Full Text] [Related]

  • 19. Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases.
    Govindarajulu S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW.
    Perit Dial Int; 2010 Sep; 30(3):311-9. PubMed ID: 20190031
    [Abstract] [Full Text] [Related]

  • 20. Vancomycin and tobramycin in the treatment of CAPD peritonitis.
    Gruer LD, Turney JH, Curley J, Michael J, Adu D.
    Nephron; 1985 Sep; 41(3):279-82. PubMed ID: 4058628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.